Literature DB >> 20092904

Normal range of alanine aminotransferase concentration is associated with carotid atherosclerosis.

Soo-Kyung Kim1, Dae-Jung Kim, Se-Hwa Kim, Yeo-Kyung Lee, Seok-Won Park, Yong-Wook Cho, Kap-Bum Huh.   

Abstract

OBJECTIVE: To investigate whether alanine aminotransferase (ALT), even within the reference range, is associated with atherosclerotic burden in apparently healthy adults.
METHODS: This was an observational study performed on 830 healthy individuals with normal ALT concentration (<or=40U/L). Atherosclerotic burden was assessed by carotid arterial intima-media thickness (IMT). All subjects were divided according to the quartile based on their ALT concentrations.
RESULTS: Despite all subjects having a normal ALT concentration, ultrasonographic liver steatosis was observed in 48.4% and 36.7% of men and women, respectively. In both genders, subjects in the highest quartile of ALT concentration had a significantly higher waist circumference, triglyceride concentration, HOMA-IR, a higher prevalence of metabolic syndrome, and a greater severity of ultrasonographic liver steatosis than did those in the lower quartiles. In women, the carotid IMT increased significantly with increasing quartiles of ALT concentration (0.62+/-0.14mm, 0.66+/-0.15mm, 0.69+/-0.15mm, vs. 0.72+/-0.24mm; P for trend<0.001). Based on multivariate regression analysis, the serum ALT, even within the normal range, was associated with the carotid IMT in both men and women, and independently of traditional cardiovascular risk factors.
CONCLUSIONS: ALT concentrations, albeit within the reference range, were associated with atherosclerotic burden in healthy adults.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20092904     DOI: 10.1016/j.diabres.2010.01.003

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  3 in total

1.  Associations of matrix metalloproteinase (MMP)-8, MMP-9, and their inhibitor, tissue inhibitor of metalloproteinase-1, with obesity-related biomarkers in apparently healthy adolescent boys.

Authors:  Youn Ho Shin; Ki Eun Kim; Yong-Jae Lee; Jae-Hwan Nam; Young Mi Hong; Hye-Jung Shin
Journal:  Korean J Pediatr       Date:  2014-12-31

2.  Efficacy Comparison of Tenofovir and Entecavir in HBeAg-Positive Chronic Hepatitis B Patients with High HBV DNA.

Authors:  Hong Shi; Mingxing Huang; Guoli Lin; Xiangyong Li; Yuankai Wu; Yusheng Jie; Yutian Chong
Journal:  Biomed Res Int       Date:  2016-03-01       Impact factor: 3.411

3.  Genetic Variants Associated with Non-Alcoholic Fatty Liver Disease Do Not Associate with Measures of Sub-Clinical Atherosclerosis: Results from the IMPROVE Study.

Authors:  Luigi Castaldo; Federica Laguzzi; Rona J Strawbridge; Damiano Baldassarre; Fabrizio Veglia; Lorenzo Vigo; Elena Tremoli; Ulf de Faire; Per Eriksson; Andries J Smit; Jiri Aubrecht; Karin Leander; Matteo Pirro; Philippe Giral; Alberto Ritieni; Giovanni Di Minno; Anders Mälarstig; Bruna Gigante
Journal:  Genes (Basel)       Date:  2020-10-22       Impact factor: 4.096

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.